Given that the abnormal levels of limonene are present in individuals with IR suggest potential NAFLD and liver damage, we investigated clinical measures of two liver specific enzymes aspartate aminotransferase (AST) and alanine aminotransferase (ALT) and systemic inflammation marker c-reactive protein (CRP). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.